-
Portola Pharmaceuticals Inc., South San Francisco, Calif. Business: Cardiovascular, Autoimmune, Cancer Date announced: 5/7/13 Type: IPO To be raised: Up to $110.4 million Shares: 6.9 million Price: $13-$16 Underwriters:…
Published on 5/13/2013
-
Cardio3 BioSciences S.A., Mont-Saint-Guibert, Belgium Business: Cardiovascular Date completed: 5/8/13 Type: Venture financing Raised: 7 million ($9.2 million) Investors: Existing investors Note: The company also …
Published on 5/13/2013
-
Discovery Laboratories Inc. (NASDAQ:DSCO), Warrington, Pa. Business: Pulmonary Date completed: 5/10/13 Type: Follow-on Raised: $14.3 million Shares: 9.5 million Price: $1.50 Shares after offering: 53.3 million …
Published on 5/13/2013
-
Idera Pharmaceuticals Inc. (NASDAQ:IDRA), Cambridge, Mass. Business: Cancer, Infectious, Autoimmune Date completed: 5/7/13 Type: Follow-on Raised: $16.5 million Shares: 17.5 million Price: $0.50 Shares after offering: …
Published on 5/13/2013
-
InflammatoRx Inc., Quebec City, Quebec Business: Inflammation Date completed: 5/7/13 Type: Venture financing Raised: Not disclosed Investor: AmorChem Venture Fund
Published on 5/13/2013
-
Isis Pharmaceuticals Inc. (NASDAQ:ISIS), Carlsbad, Calif. Business: Cancer, Endocrine/Metabolic, Cardiovascular Date completed: 5/8/13 Type: Follow-on Raised: $171 million Shares: 9 million Price: $19 Shares after …
Published on 5/13/2013
-
Lumena Pharmaceuticals Inc., San Diego, Calif. Business: Hepatic Date completed: 5/8/13 Type: Venture financing Raised: $23 million Investors: Alta Partners; Pappas Ventures; RiverVest Venture Partners
Published on 5/13/2013
-
NeuroPhage Pharmaceuticals Inc., Cambridge, Mass. Business: Neurology Date completed: 5/6/13 Type: Venture financing Raised: $6.4 million Investors: Merieux Developpement; Shire plc; existing investors
Published on 5/13/2013
-
Receptos Inc. (NASDAQ:RCPT), San Diego, Calif. Business: Autoimmune, Cancer, Inflammation Date completed: 5/8/13 Type: IPO Raised: $72.8 million Shares: 5.2 million Price: $14 Shares after offering: 17.6 million …
Published on 5/13/2013
-
Silence Therapeutics plc (LSE:SLN), London, U.K. Business: Cancer, Renal, Ophthalmic Date completed: 4/29/13 Type: Placing Raised: 19 million ($29.6 million) Shares: 9.5 million Price: 200p Shares after offering: 47 …
Published on 5/13/2013
-
Sirona Biochem Corp. (TSX-V:SBM; OTCQX:SRBCF), Vancouver, B.C. Business: Endocrine/Metabolic Date completed: 5/3/13 Type: Debt financing Raised: $600,000 Investors: Company director; not disclosed Note: The 18-month …
Published on 5/13/2013
-
Sirona Biochem Corp. (TSX-V:SBM; OTCQX:SRBCF), Vancouver, B.C. Business: Endocrine/Metabolic Date completed: 5/3/13 Type: Private placement of units Raised: $375,000 Units: 3.8 million Price: $0.10 (unit) Shares after …
Published on 5/13/2013
-
SQI Diagnostics Inc. (TSX-V:SQD), Toronto, Ontario Business: Diagnostic Date completed: 5/3/13 Type: Private placement of units Raised: C$3.8 million (US$3.8 million) Units: 5.1 million Price: C$0.75 (unit) Shares after…
Published on 5/13/2013
-
Stat-Diagnostica and Innovation, Barcelona, Spain Business: Diagnostic Date completed: 5/6/13 Type: Venture financing Raised: $22.1 million Investors: Kurma Life Sciences Partners; Idinvest Partners; Boehringer …
Published on 5/13/2013
-
Tacurion Pharma Inc., Bridgewater, N.J. Business: Genitourinary Date completed: 5/7/13 Type: Venture financing Raised: $15 million Investors: InterWest Partners; Sutter Hill Ventures; Astellas Venture
Published on 5/13/2013
-
Trevena Inc., King of Prussia, Pa. Business: Cardiovascular, Neurology, Autoimmune Date completed: 5/9/13 Type: Venture financing Raised: $60 million Investors: Forest Laboratories Inc.; Alta Partners; HealthCare …
Published on 5/13/2013
-
Zalicus Inc. (NASDAQ:ZLCS), Cambridge, Mass. Business: Autoimmune, Neurology, Inflammation Date completed: 5/8/13 Type: Private placement Raised: $2 million Shares: 3.3 million Price: $0.61 Shares after offering: 130.6 …
Published on 5/13/2013
-
Frazier Healthcare, Seattle, Wash. Business: Finance Date announced: 5/8/13 Frazier Healthcare raised $281.8 million of a planned $300 million for its seventh fund, Frazier Healthcare VII, according to an SEC filing. …
Published on 5/13/2013
-
Good Start Genetics Inc., Cambridge, Mass. Business: Diagnostic Date announced: 5/8/13 Good Start secured a loan facility from Capital Royalty for up to $28 million.
Published on 5/13/2013
-
Innovus Pharmaceuticals Inc. (OTCBB:INNV), San Diego, Calif. Business: Dermatology, Cancer Date announced: 5/6/13 Innovus increased to $1 million from $500,000 an 8% convertible debenture commitment from President and …
Published on 5/13/2013
-
Insys Therapeutics Inc. (NASDAQ:INSY), Phoenix, Ariz. Business: Neurology, Drug delivery Date announced: 5/7/13 Insys raised $4.8 million through the sale of 600,000 shares at $8 to cover the overallotment from its May …
Published on 5/13/2013
-
InVivo Therapeutics Holdings Corp. (OTCBB:NVIV), Cambridge, Mass. Business: Neurology Date announced: 5/3/13 InVivo issued a call notice for the early exercise of warrants issued on Oct., 26, 2010; Nov. 10, 2010; and …
Published on 5/13/2013
-
Jazz Pharmaceuticals plc (NASDAQ:JAZZ), Dublin, Ireland Business: Neurology, Endocrine/Metabolic Date announced: 5/7/13 Jazz said its board authorized the repurchase of up to $200 million of the company's stock. The …
Published on 5/13/2013
-
Shire plc (LSE:SHP; NASDAQ:SHPG), Dublin, Ireland Business: Neurology, Gastroitestinal, Endocrine/Metabolic Date announced: 5/2/13 Shire disclosed in its 1Q13 earnings that, as of April 30, it had repurchased 7.4 …
Published on 5/13/2013
-
Supernus Pharmaceuticals Inc. (NASDAQ:SUPN), Rockville, Md. Business: Neurology, Drug delivery Date announced: 5/6/13 Supernus raised $15 million through the sale of senior convertible notes following the exercise by …
Published on 5/13/2013